Learning and research

User account menu

Join
Log in

Main navigation

Upcoming events
Learning and research
IDDI Workstreams & Task Forces
Membership
Pulmonary hypertension
Support us
About us

User account menu

Join
Log in

Breadcrumb

Home
Learning and Research

Pagination

Previous page
Page 5

Related content

GoDeep Global PH Registry
Pulmonary Circulation
Pulmonary Hypertension Global Patient Survey (PH GPS)
Latest news

Fulltext search

Reset filters

Fulltext search

Publication Types

Pulmonary Circulation
IDDI Workstream or Task Force Learning
PVRI Digital Webinar Series
PVRI Community Calls
PVRI 2025 Rio
PVRI 2024 London
PVRI 2023 DDDS
PVRI 2022 Athens

Subjects

Basic research and pathophysiology
- Cellular and molecular biology
- Extra-pulmonary vascular cell and tissue types
- Genetics/genomics and other Omics
- Immunology and inflammation
- Infections and PVD
- Right ventricle
Diagnostic and assessment methods
- 1MWT, 6MWT, Incremental shuttle walk test
- Biomarkers
- Cardiopulmonary exercise test
- Genetic markers
- Hemodynamic assessments
- Imaging techniques
- Pulmonary function test
Diseases and clinical manifestations
- Group 1: Pulmonary Arterial Hypertension (PAH)
- Group 2: PH associated with left heart disease
- Group 3: PH associated with lung disease and/or hypoxia
- Group 4: PH associated with pulmonary artery obstruction / CTEPH
- Group 5: PH with unclear and/or multifactorial mechanisms
- Paediatric PH
Emerging trends and future research
- Emerging therapies
- Novel clinical trial designs in PH
- Policy and guidelines
- Technological advances
Epidemiology and public health
- Global health and PH
- Incidence, prevalence, and risk factors
- Population studies and public health initiatives
Patient care and advocacy
- Advocacy and quality of life improvement
- Palliative care in PH
- Psychosocial aspects and patient education
- Special circumstances
- Symptom management
Treatment
- Perioperative care
- PH-specific therapies
- Special populations
- Supportive therapy
- Surgical and interventional procedures

31 January 2025

Pulmonary Hypertension (PH) is highly prevalent in rheumatic heart disease in sub-Saharan African

An oral presentation delivered at PVRI 2025 Congress by Katarina Zeder, University of Maryland - Institute for Health Computing

Members Only

Member content

31 January 2025

Congenital heart disease & the pulmonary vasculature

Presented at PVRI 2025 Congress by Shahin Moledina, Great Ormond Street Hospital NHS Trust

Members Only

Member content

31 January 2025

Effects of Dapagliflozin on Pulmonary Hypertension (PH) in a rat Pulmonary Vein Banding (PVB) model

Presented at PVRI 2025 Congress by Leonhard Blumrich, Cardio-Pulmonary Institute (CPI)

Members Only

Member content

31 January 2025

How do HFrEF & HFpEF affect the pulmonary vasculature & how can we model it?

Presented at PVRI 2025 Congress by Charly Lai, Indiana University Indianapolis

Members Only

Member content

31 January 2025

The vasculature in CLD: Imaging insights

Presented at PVRI 2025 Congress by Farbod (Nick) Rahaghi, Brigham and Women's Hospital

Members Only

Member content

31 January 2025

Wenshen Yiqi Granule Alleviates Chronic Obstructive Pulmonary Disease via the Long Noncoding RNA-XIST/MicroRNA-200c-3p Axis

Chronic obstructive pulmonary disease (COPD) is a major challenge to global public health. Evidence showed that long noncoding RNA (lncRNA)-XIST/microRNA (miRNA)-200c-3p axis regulated apoptosis and inflammation in cigarette smoke extract (CSE)-exposed human bronchial epithelial cells.

Pulmonary Circulation

31 January 2025

Endotyping pulmonary hypertension (PH) in COPD: possible role of systematic & lung iron status

An oral presentation delivered at PVRI 2025 Congress by Horst Olschewski, Sigmund Freud Private University

Members Only

Member content

30 January 2025

Approach to treatment of Group I patients with co-morbidities

Presented at PVRI 2025 Congress by Anna Hemnes, Vanderbilt University Medical Center

Members Only

Member content

30 January 2025

Global treatment disparities within high- and middle-high income PH centers: A cluster analysis by the PVRI IDDI Access to Care Workstream

An oral presentation delivered at PVRI 2025 Congress by Franz Rischard, University of Arizona

Members Only

Member content

30 January 2025

Medical & surgical management of CTED & CTEPH

Presented at PVRI 2025 Congress by Hiromi Matsubara, National Hospital Organization Okayama Medical Center

Members Only

Member content

Pagination

First page First

Previous page Previous

…

Page 5

Current page 6

Page 7

Page 8

…

Next page Next

Last page Last

Footer Menu

GET LEARNING
- Attend an event
- Keep up with PVD developments
GET CONNECTED
GET INVOLVED

Footer menu - pages

Accessibility
Code of Conduct
Complaints
Cookies & Privacy Policy
Social Media Policy
Terms & Conditions

The Pulmonary Vascular Research Institute (PVRI) is a charity registered in England & Wales no. 1127115 and a Company Limited by Guarantee no. 05780068. VAT registration no. 488 0247 66. Registered office: 5 Tanner Street, London SE1 3LE. Phone number: + 44 (0) 7934 126930.

Translate this page